Skip to main content
. Author manuscript; available in PMC: 2020 Mar 7.
Published in final edited form as: Nanoscale. 2019 Mar 7;11(10):4531–4545. doi: 10.1039/C8NR07667G

Figure 7.

Figure 7

TEM images of ultrathin sections of HepG2 cells exposed to MSNs-Tf-AgNPs. Control cells (A), HepG2 cells exposed to 25 μg/mL for 24 h (B and C) and 50 μg/mL for 48 h (D and E) of MSNs-Tf-AgNPs. EDX analysis of treated cells (F). Arrows indicate the localization of MSNs.